Tizanidine
Product Images NDC 10544-890

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 10544-890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label Tizanidine Tabs 4mg Bpi(10544 890 30) Dr Reddys(55111 180 10) Rev1)

This is a description of a medication called Tizanidine in the form of tablets. Each tablet contains 4mg of Tizanidine. It is available in a pack of 30 tablets and requires a prescription. The dosage instructions are available in the package insert. The tablets should be stored at room temperature between 15-30°C and in a container that is resistant to light. The text also provides details on the manufacturer, lot numbers, and expiration dates of various versions of the medication.*

FDA Label Image

Figure 1 (Fig1)

FDA Label Image

Figure 2 (Fig2)

The text describes the Improvement in Ashworth score at different weeks during a study. The study used Zanidine at a mean dose of 28.6mg. The Ashworth score is an assessment of muscle tone spasticity. The study lasted 7 weeks, and the endpoint for maintenance was observed at the last observation from Study Week-7 using the Garred forward technique.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.